Because Aβ pathology has been reported to appear before the onset of AD,12 and also to precede to tau pathology as well as neuronal loss in AD,3 the modulation of Aβ pathology needs to be started in the earlier stage of AD or before the onset of AD, ideally. This evidence concerns the gene MAPT and Alzheimer disease.